Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E N van Roon

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pharmacy and Therapeutics|January 24, 2008
Treatment of pregnant and non-pregnant rheumatic patients: a survey among Dutch rheumatologistsF Vroom, M A J F van de Laar, E N van Roon, et al.
Respiratory Medicine|September 27, 2023
The perceived waning of biologics in severe asthmaJ A Kroes, L H G Van Hal, L Van Dijk, et al.
Annals of the Rheumatic Diseases|January 16, 2007
Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot studyJ M van Woerkom, A A Kruize, R Geenen, et al.
Annals of the Rheumatic Diseases|July 18, 2008
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with goutM K Reinders, C Haagsma, T L Th A Jansen, et al.
European Journal of Clinical Pharmacology|March 5, 2017
The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort studyB E Oortgiesen, E N van Roon, P Joosten, et al.
British Journal of Clinical Pharmacology|August 27, 2005
Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuationE N van Roon, M Hoekstra, H Tobi, et al.
British Journal of Clinical Pharmacology|July 17, 2004
Leflunomide in active rheumatoid arthritis: a prospective study in daily practiceE N Van Roon, T L Th A Jansen, L Mourad, et al.
British Journal of Clinical Pharmacology|May 21, 2004
Leflunomide in active rheumatoid arthritis: a prospective study in daily practiceE N Van Roon, T L Th A Jansen, L Mourad, et al.
Annals of the Rheumatic Diseases|September 4, 2004
Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritisE N van Roon, T L T A Jansen, M A F J van de Laar, et al.
Annals of the Rheumatic Diseases|February 6, 2008
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinolM K Reinders, E N van Roon, T L Th A Jansen, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacy and Therapeutics|January 24, 2008
Treatment of pregnant and non-pregnant rheumatic patients: a survey among Dutch rheumatologistsF Vroom, M A J F van de Laar, E N van Roon, et al.
Respiratory Medicine|September 27, 2023
The perceived waning of biologics in severe asthmaJ A Kroes, L H G Van Hal, L Van Dijk, et al.
Annals of the Rheumatic Diseases|January 16, 2007
Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot studyJ M van Woerkom, A A Kruize, R Geenen, et al.
Annals of the Rheumatic Diseases|July 18, 2008
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with goutM K Reinders, C Haagsma, T L Th A Jansen, et al.
European Journal of Clinical Pharmacology|March 5, 2017
The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort studyB E Oortgiesen, E N van Roon, P Joosten, et al.
British Journal of Clinical Pharmacology|August 27, 2005
Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuationE N van Roon, M Hoekstra, H Tobi, et al.
British Journal of Clinical Pharmacology|July 17, 2004
Leflunomide in active rheumatoid arthritis: a prospective study in daily practiceE N Van Roon, T L Th A Jansen, L Mourad, et al.
British Journal of Clinical Pharmacology|May 21, 2004
Leflunomide in active rheumatoid arthritis: a prospective study in daily practiceE N Van Roon, T L Th A Jansen, L Mourad, et al.
Annals of the Rheumatic Diseases|September 4, 2004
Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritisE N van Roon, T L T A Jansen, M A F J van de Laar, et al.
Annals of the Rheumatic Diseases|February 6, 2008
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinolM K Reinders, E N van Roon, T L Th A Jansen, et al.
Pageof 5